pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
Rare Disease · news · pharmadog
← back to Rare Disease
News mentioning Rare Disease
225
stories
Jul 9, 26
Who’s going to run the FDA?
stat
Jul 9, 26
STAT+: AstraZeneca, Ionis report major trial failure with heart disease drug
stat
Jul 9, 26
STAT+: The quest to save Grace — and clear the way for rare disease patients everywhere
stat
Jul 8, 26
STAT+: Prime Medicine claims victory in dispute over gene-editing technology with Beam Therapeutics
stat
Jul 8, 26
STAT+: Pharmalittle: We’re reading about a Vera kidney drug approval, a U.K. Enhertu pricing deal, and more
stat
Jul 8, 26
Prime wins gene editing dispute; Saol claims latest post-Makary FDA reversal
biopharma dive
Jul 8, 26
Are glucose monitors a good thing for 2-year-olds? Experts look at risks, benefits
stat
Jul 2, 26
STAT+: A year after distressed buyout, what’s become of Bluebird Bio?
stat
Jul 1, 26
Ipsen to buy Swiss biotech Memo Therapeutics in potential $800M deal
biopharma dive
Jul 1, 26
STAT+: More signs that GLP-1s may help with peripheral artery disease
stat
Jun 29, 26
Theravance, after clinical setbacks, agrees to $929M buyout
biopharma dive
Jun 29, 26
10 clinical trials to watch in the second half of 2026
biopharma dive
Jun 26, 26
Alkermes’ incoming CEO has a plan to outplay Lilly and Takeda
biopharma dive
Jun 25, 26
De-Risking a Rare Disease Launch Starts with Precision
fiercebiotech
Jun 19, 26
Federal grant delays could jeopardize essential disability services, research
stat
Jun 18, 26
Moderna flu vaccine wins unanimous support from FDA panel
biopharma dive
Jun 17, 26
UniQure to file gene therapy for approval, reflecting major shifts at FDA
biopharma dive
Jun 15, 26
Covid vaccination cut risk of adverse heart events, large study finds
stat
Jun 12, 26
STAT+: Pharmalittle: We’re reading about a discontinued cancer drug, a Novo security breach, and more
stat
Jun 11, 26
Nonprofit buys experimental cancer drug to maintain patient access
stat
Jun 11, 26
J&J looks to widen Imaavy’s use; $300M backs rare disease drug launch
biopharma dive
Jun 10, 26
Rare disease biotech Beren adds $300M from new financings
endpoints
Jun 9, 26
Grace Science says FDA bottleneck jeopardizes rare disease therapy
endpoints
Jun 8, 26
STAT+: J&J spends $1 billion to enter KRAS race for cancer treatments
stat
Jun 5, 26
Industry seeks more clarity on commissioner's voucher program
endpoints
Jun 4, 26
Acting FDA commissioner pledges to prevent political interference in rare disease meeting
endpoints
Jun 4, 26
STAT+: Pharmalittle: We’re reading about fewer pharma investments in Germany, growing U.S. layoffs, and more
stat
Jun 2, 26
STAT+: Pharmalittle: We’re reading about a Lilly threat to 340B hospitals, Ebola vaccine funding, and more
stat
Jun 1, 26
STAT+: At the world’s largest cancer research meeting, data briefly took a backseat to grief
stat
Jun 1, 26
RallyBio tries again for reverse merger, this time with Avenzo
biopharma dive
← prev
page 6 of 8
next →
